Solid Biosciences Inc.
SLDB
$7.26
$0.212.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.80% | -63.16% | -69.90% | -54.77% | -29.87% |
| Total Depreciation and Amortization | -33.36% | -23.99% | -28.65% | 13.63% | -4.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.82% | 126.08% | 302.27% | 208.09% | 138.61% |
| Change in Net Operating Assets | -339.37% | 577.99% | 223.87% | 169.31% | 132.14% |
| Cash from Operations | -56.27% | -45.17% | -43.61% | -16.74% | -6.19% |
| Capital Expenditure | -76.30% | -46.67% | 20.48% | 45.51% | 56.83% |
| Sale of Property, Plant, and Equipment | 1,600.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -271.74% | -649.85% | -44.35% | 93.17% | -237.78% |
| Cash from Investing | -263.38% | -614.98% | -41.77% | 92.34% | -266.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -52.85% | -87.83% | -133.33% | -- | -- |
| Issuance of Common Stock | 53.76% | 63.49% | 69.82% | 78.70% | 4,000.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 67.11% | 67.11% | 67.11% | 93.66% | -- |
| Cash from Financing | 58.81% | 69.17% | 75.90% | 85.68% | 3,821.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -420.19% | -119.65% | 887.92% | 297.97% | 107.79% |